Maternal obesity and increased risk for autism and developmental delay among very preterm infants

L C Reynolds1, T E Inder2, J J Neil3

  • 11] Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA [2] Department of Pediatrics, Washington University School of Medicine, St Louis, MO, USA.

Insights

Maternal obesity in women delivering very preterm infants was linked to increased autism risk and lower language scores in children at age 2. This highlights the need for targeted surveillance in high-risk pregnancies.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Public Health

Background:

  • Maternal obesity affects 35% of women of child-bearing age.
  • Maternal obesity may increase risks for adverse neurodevelopmental outcomes.
  • Limited research exists on maternal obesity and neurodevelopment in preterm infants.

Purpose of the Study:

  • To investigate the association between maternal obesity and neurodevelopmental outcomes in very preterm children at 2 years of age.
  • To determine if maternal pre-pregnancy body mass index is associated with neurodevelopmental differences in offspring born preterm.

Main Methods:

  • Prospective cohort study of 62 maternal/infant dyads born at or before 30 weeks gestation.
  • Mothers classified as obese or non-obese based on pre-pregnancy BMI.
  • Infants assessed with MRI at term equivalent and developmental testing at age 2.

Main Results:

  • Maternal obesity was significantly associated with a positive screen for autism (OR=9.88, P=0.002).
  • Maternal obesity correlated with lower composite language scores (β=-9.36, P=0.002).

Conclusions:

  • Maternal obesity is linked to adverse neurodevelopmental outcomes in very preterm children at age 2.
  • Findings suggest a need for targeted surveillance of infants born to obese mothers.
  • Further research is required to replicate these findings.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
2.0K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K